News
12-12-2024, 10:35 AM
Patients with intermediate-risk breast cancer had similar rates of 10-year overall survival whether or not they underwent chest wall irradiation (CWI) after mastectomy, according to results from the BIG 2-04 MRC SUPREMO clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
More... (https://www.news-medical.net/news/20241212/Chest-wall-irradiation-does-not-impact-10-year-survival-in-intermediate-risk-breast-cancer.aspx)
More... (https://www.news-medical.net/news/20241212/Chest-wall-irradiation-does-not-impact-10-year-survival-in-intermediate-risk-breast-cancer.aspx)